Biomarkers to optimize PSMA-targeted radioligand therapy for metastatic castration-resistant prostate cancer

Himisha Beltran, Jeremie Calais, Louise Emmett, Phillip H. Kuo, Christopher J. Logothetis

Open source

DOI: 10.3389/fonc.2025.1583168
Published: 2025-08-20
Container: Frontiers in Oncology
Publisher: Frontiers Media SA
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2025.1583168,
  title = {Biomarkers to optimize PSMA-targeted radioligand therapy for metastatic castration-resistant prostate cancer},
  author = {Himisha Beltran and Jeremie Calais and Louise Emmett and Phillip H. Kuo and Christopher J. Logothetis},
  year = {2025},
  journal = {Frontiers in Oncology},
  doi = {10.3389/fonc.2025.1583168},
  url = {https://doi.org/10.3389/fonc.2025.1583168}
}

RIS

TY  - JOUR
TI  - Biomarkers to optimize PSMA-targeted radioligand therapy for metastatic castration-resistant prostate cancer
AU  - Himisha Beltran
AU  - Jeremie Calais
AU  - Louise Emmett
AU  - Phillip H. Kuo
AU  - Christopher J. Logothetis
PY  - 2025
JO  - Frontiers in Oncology
DO  - 10.3389/fonc.2025.1583168
UR  - https://doi.org/10.3389/fonc.2025.1583168
ER  -

APA

Beltran, H., Calais, J., Emmett, L., Kuo, P. H., & Logothetis, C. J. (2025). Biomarkers to optimize PSMA-targeted radioligand therapy for metastatic castration-resistant prostate cancer. Frontiers in Oncology. https://doi.org/10.3389/fonc.2025.1583168

Source records

crossref · retrieved 2026-09-27T01:24:32.559Z